Koers Eidos Therapeutics, Inc.
Aandelen
EIDX
US28249H1041
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Neil Kumar
CEO | Chief Executive Officer | 45 | 01-03-16 |
Jonathan Fox
PSD | President | 67 | 01-10-16 |
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 01-06-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 01-06-16 |
Jonathan A. Barr
BRD | Director/Board Member | - | 26-01-21 |
Jonathan Fox
PSD | President | 67 | 01-10-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |